Monday, October 5, 2026

Technology Sector Trading

8 articles

Semiconductor Stocks Sink 25% as SOXX Corrects Even as Amkor Posts Record Results

Semiconductor Stocks Sink 25% as SOXX Corrects Even as Amkor Posts Record Results

The SOXX semiconductor index has fallen roughly 25% from its highs, with leveraged chip ETFs down more than 60%, even as Amkor Technology reported record results and AI-server demand stayed strong. The gap reflects investors pricing in competitive risk from Chinese chipmakers and slowing growth rates faster than order books have actually turned, while Washington and Nvidia keep committing fresh capital to the sector.

LM Salvado•
SOXX Semiconductor ETF Jumps 79% YTD as AI Chip Race Fuels US-China Tech Split

SOXX Semiconductor ETF Jumps 79% YTD as AI Chip Race Fuels US-China Tech Split

The iShares Semiconductor ETF (SOXX) is up 79% year to date and roughly 152% over one year as of June 5, 2026, driven by surging AI compute and memory demand. Vicor Corporation posted $471.7 million in trailing revenue and $136.7 million in net income, reaching an $11.3 billion market cap. Meanwhile, US rare-earth restrictions and China's homegrown Zhenwu chip line signal a deepening split in global chip supply chains.

LM Salvado•
Olix Targets 2027 Product Launch as AI Chip Market Heads Toward $1 Trillion Milestone

Olix Targets 2027 Product Launch as AI Chip Market Heads Toward $1 Trillion Milestone

Olix plans to ship its first specialized AI chip product in 2027 as the semiconductor industry races toward Nvidia's projected $1 trillion in chip sales through 2027. The expansion includes Micron acquiring fabrication facilities for High-Bandwidth Memory and Meta committing $12B to AI infrastructure partnerships.

LM Salvado•
KLA Projects Mid-to-High Teens Growth in Advanced Packaging as AI Chips Drive Equipment Demand

KLA Projects Mid-to-High Teens Growth in Advanced Packaging as AI Chips Drive Equipment Demand

KLA Corporation forecasts mid-to-high teens growth in advanced packaging equipment for calendar 2026, outpacing traditional semiconductor manufacturing growth. The surge reflects AI accelerator demand requiring 2.5D and 3D chip packaging architectures. Lumentum posted 65% year-over-year revenue growth, signaling broader industry momentum in advanced packaging technologies.

ViaNews Editorial Team (Markets)•
Photonics Suppliers Undershipping AI Demand by 30% as Multi-Year Contracts Lock Capacity Through 2027

Photonics Suppliers Undershipping AI Demand by 30% as Multi-Year Contracts Lock Capacity Through 2027

Lumentum is undershipping customer demand by approximately 30% as AI infrastructure orders overwhelm production capacity. All externally modulated laser (EML) capacity is committed through late 2027, while the optical communications segment backlog exceeds $400 million. Indium phosphide fab capacity expanded 20% in Q4 alone, yet demand-supply gaps continue widening.

ViaNews Editorial Team (Markets)•
Semiconductor Supply Crunch Deepens as AI Memory Demand Triggers $3B Packaging Capex Wave

Semiconductor Supply Crunch Deepens as AI Memory Demand Triggers $3B Packaging Capex Wave

DRAM and HBM shortages are spreading across electronics sectors as AI infrastructure buildout creates persistent supply tightness. Amkor plans $2.5-3B in advanced packaging capex while hyperscaler investments shift from COVID-era panic buying to sustained data center expansion. The cycle shows structural demand characteristics that break from traditional semiconductor boom-bust patterns.

ViaNews Editorial Team (Markets)•
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,340 source documents archived
Query this data → isubstrate.com